Foresee Pharmaceuticals , Ltd. Common Stock

The latest common stock for 6576.TWO is $1.6B as of June 2026. That compares with $1.5B in the prior-year period — up 1.7% year over year. Investors often review this figure alongside Foresee Pharmaceuticals , Ltd.'s historical trend and sector peers before judging valuation or financial health.

Over the past year, 6576.TWO's common stock moved from $1.5B to $1.6B — a 1.7% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Foresee Pharmaceuticals , Ltd.'s operating scale or balance-sheet position.

A common stock figure of $1.6B for 6576.TWO is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting 6576.TWO's common stock ($1.6B), review year-over-year change from $1.5B, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.